The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells
Pancreatic ductal adenocarcinoma is currently one of the deadliest cancers with low overall survival rate. This disease leads to an aggressive local invasion and early metastases and is poorly responsive to treatment with chemotherapy or chemoradiotherapy. Several studies have shown that pancreatic cancer stem cells (PCSCs) play different roles in the regulation of drug resistance and recurrence in pancreatic cancer. MicroRNA (miRNA), a class of newly emerging small noncoding RNAs, is involved in the modulation of several biological activities ranging from invasion to metastases development, as well as drug resistance of pancreatic cancer. In this review, we synthesize the latest findings on the role of miRNAs in regulating different biological properties of pancreatic cancer stem cells.
Top-30
Journals
|
1
2
|
|
|
International Journal of Molecular Sciences
2 publications, 13.33%
|
|
|
Current Medicinal Chemistry
1 publication, 6.67%
|
|
|
Cells
1 publication, 6.67%
|
|
|
European Journal of Pharmacology
1 publication, 6.67%
|
|
|
Seminars in Cancer Biology
1 publication, 6.67%
|
|
|
Biomedicine and Pharmacotherapy
1 publication, 6.67%
|
|
|
Journal of Cellular and Molecular Medicine
1 publication, 6.67%
|
|
|
Cancers
1 publication, 6.67%
|
|
|
Journal of Cancer Metastasis and Treatment
1 publication, 6.67%
|
|
|
Advanced Drug Delivery Reviews
1 publication, 6.67%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
6
7
8
|
|
|
Elsevier
8 publications, 53.33%
|
|
|
MDPI
4 publications, 26.67%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 6.67%
|
|
|
Wiley
1 publication, 6.67%
|
|
|
OAE Publishing Inc.
1 publication, 6.67%
|
|
|
1
2
3
4
5
6
7
8
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.